Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Observational Study Guidance Needed For CER – Vanderbilt’s Harrell

Executive Summary

With members of the Patient-Centered Outcomes Research Institute’s Methodology Committee expected to be named by early in 2011, one area where they could start to improve comparative effectiveness research is in providing solid guidance for conducting observational studies.

You may also be interested in...

PCORI Should Take Lead On Public CER Inventory, Pharma Groups Tell HHS

Development of a publicly available repository of comparative effectiveness research should grow out of the work of the soon-to-be established Patient Centered Outcomes Research Institute, groups representing pharmaceutical industry interests urged in recent comments to HHS

CER Policy Does Not Equate To Head-To-Head Trials, UBC's Luce Says

While there are many fears that comparative effectiveness research will be used to pick winners and losers when products are pitted against one another, United BioSource Corp.'s Bryan Luce does not see head-to-head trials becoming the primary focus of CER activity in the U.S., at least on the federal level

WellPoint's CER Guide Describes How It Will Determine Usefulness Of Studies

WellPoint has released guidelines for the submission and evaluation of comparative effectiveness research that it will use in reviewing drugs for its formulary

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts